Theratechnologies to Present at the Canaccord Genuity 42nd Annual Growth Conference
02 August 2022 - 1:30PM
Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX:
TH) (NASDAQ: THTX), a biopharmaceutical company focused on the
development and commercialization of innovative therapies, today
announced that Paul Levesque, President and Chief Executive
Officer, will participate in a fireside chat at the Canaccord
Genuity 42nd Annual Growth Conference on Wednesday, August 10, 2022
at 1:00 p.m. ET.
A live webcast of the event can be accessed here
and through the investor relations section of the Company’s website
under ‘Events’. An archive will also be available for 90 days
following the conference.
About Theratechnologies
Theratechnologies (TSX: TH) (NASDAQ: THTX) is a
biopharmaceutical company focused on the development and
commercialization of innovative therapies addressing unmet medical
needs. Further information about Theratechnologies is available on
the Company's website at www.theratech.com, on SEDAR at
www.sedar.com and on EDGAR at www.sec.gov.
Investor Contact:
Elif McDonald
Senior Director, Investor Relations
ir@theratech.com
1-438-315-8563
Media Contact:
Julie Schneiderman
Senior Director, Communications & Corporate Affairs
communications@theratech.com
1-514-336-7800
Theratechnologies (TSX:TH)
Historical Stock Chart
Von Mär 2024 bis Apr 2024
Theratechnologies (TSX:TH)
Historical Stock Chart
Von Apr 2023 bis Apr 2024